InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$85.81

2026-10-16

Market Cap

$14.6B

Volume

0.9M

52-Wk High

$94.16

52-Wk Low

$62.38

Trailing PE

10.4

P/S

1.76

Gross Margin

54.7%

Net Margin

17.3%

ROE

29%

ROIC

16%

Piotroski

7/9

Altman Z

2.2

1-Yr Return

+20.1%

5-Yr Return

+24.2%

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

SectorHealthcareIndustryMedical - Instruments & SuppliesExchangeNYSEMarket Cap$14.6BEmployees10,000 (SEC-filed)CEOBryan C. HansonIPO2024-04-01CountryUS

1750 Yankee Doodle Road, Eagan, MN 55121 · Tel 651-733-1110 · solventum.com

INSIDERSTREET SCORE37 / 100Street mean $101.00 (6 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALNET BUYING$0.1M open-market purchases vs $0.0M sales / 6 mo

1 Year vs S&P 500 · SOLV +20.1% · S&P 500 +15.9% · spread +4.2pp

2 Years vs S&P 500 · SOLV +24.2% · S&P 500 +49.6% · spread -25.4pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE37of 100

Score Breakdown

Profitability	55/100
Growth	59/100
Momentum	49/100
Quality	52/100
Earnings Quality	35/100
Balance Sheet	49/100
Value	67/100
Risk (safety)	50/100
Overall	37.3/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
BAX	32
HOLX	56
RGEN	64
AVTR	20
COO	69
ATR	55
SOLV	37

IS Score Trend — quarterly

9 quarters, 24 Q2 to 26 Q2. Peak 49 in 25 Q3, latest 37 — -12 since. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY37 / 100IS Score 37.3 / 100 · -12.2 from peak of 49

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTURELEAN BEARISHTechnical Score 36 / 100 · Power -27 · 7 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit below the midpoint — business quality at 37 and price structure at 36 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 55 and holds two consecutive quarters	now 37.3	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 49 → 47 → 36 → 37	the direction matters more than the level
Technical vote share back above 50%	now 18%	price structure no longer broken
Institutional holder count rises two quarters running	peak 938 → now 885	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score2 of 4top 13% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)2 buys2026-05-01

Insider Buys (180d)0none disclosed

ETF Funds (30d)465 up / 473 downnet -8 funds

Institutions Added (13F)4managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 10 quarters

Peak 938 · latest 885 (-53 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	885	129.1M	$9.9B	74.4%
2026 Q1	881	128.7M	$8.3B	74.2%
2025 Q4	938	126.1M	$9.9B	72.7%
2025 Q3	863	121.8M	$8.9B	70.2%
2025 Q2	883	115.0M	$8.7B	66.3%
2025 Q1	908	114.6M	$8.7B	66.0%
2024 Q4	933	110.1M	$7.2B	63.4%
2024 Q3	924	107.5M	$7.5B	62.0%
2024 Q2	895	105.4M	$5.5B	60.8%
2024 Q1	63	2.2M	$0.1B	1.3%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Hanson Bryan C	director, Chief Executive Officer	2026-09-01	EXERCISE	67,261	—	211,983
Hanson Bryan C	director, Chief Executive Officer	2026-09-01	TAX W/H	26,468	$2.41M	185,515
Hanson Bryan C	director, Chief Executive Officer	2026-09-01	EXERCISE	67,261	—	0
Zieselman Neil Craig	SVP, Controller & CAO	2026-08-17	A-Award	6,911	—	6,911
Alban Carlos	director	2026-05-15	A-Award	3,300	—	3,300
Cox Carrie Smith	director	2026-05-15	A-Award	4,848	—	4,848
Devore Susan D.	director	2026-05-15	A-Award	3,300	—	3,300
Edwards Shirley Ann	director	2026-05-15	A-Award	3,300	—	3,300

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
P — Open-market purchases	1	1,475	$0.1M	Counted
M — Exercises (paired A/D)	37	255,850	—	None — mechanics
F — Tax withholding	15	72,121	$5.7M	None — compensation

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalNet Buying

Open-Market Sells$0.0M0 txns / 6 mo

Open-Market Buys$0.1M1 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Form	Reporting person	% of class	Shares
2026-03-27	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2026-01-27	SCHEDULE 13G/A	Independent Franchise Partners, LLP	8.85%	15.4M sh
2025-11-13	SCHEDULE 13G/A	Independent Franchise Partners, LLP	7.44%	12.9M sh
2025-08-18	SCHEDULE 13G/A	3M Company	14.80%	25.6M sh

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	BUY	$1,001 - $15,000	2026-05-01	2026-06-11
James French Hill	House	SELL	$15,001 - $50,000	2025-12-31	2026-01-26
French Hill	House	SELL	$15,001 - $50,000	2025-12-31	2026-01-23
Alan Armstrong	Senate	BUY	$1,001 - $15,000	2026-03-27	2026-07-21
Ron Wyden	Senate	SELL	$1,001 - $15,000	2025-02-06	2025-02-21
Ron Wyden	Senate	SELL	$1,001 - $15,000	2025-02-06	2025-02-20

House 12-Mo4 trades1 purchases

Senate 12-Mo1 trades1 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)881

13F Shares129M74.2% of shares out

New / Closed84 / 126positions, QoQ

Increased / Reduced274 / 278positions, QoQ

Put/Call (13F)1.00option positions

Free Float84.9%145M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Assenagon Asset Management S.A.	482,930	$43M
Wedge Capital Management L L P/Nc	292,954	$26M
Wealth Enhancement Advisory Servic	46,274	$4M
Czech National Bank	41,573	$4M
Gateway Investment Advisers Llc	29,745	$3M
Td Waterhouse Canada Inc.	26,301	$2M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.0%	$404M
VTSAX	0.0%	$404M
VSMPX	0.0%	$404M
VTI	0.0%	$404M
VFIAX	0.0%	$335M
VFFSX	0.0%	$335M

13F Filers Holding SOLV — quarterly

Institutional Put/Call — quarterly

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session41.9%2026-10-15

20-Day Avg52.1%50-day 52.9%

TrendFalling20d vs 50d

By Market CenterQ: 41% · N: 56% · B: 57%latest session

Weekly Notional ($B)

Where SOLV Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	1.0M	37 sh
Ubsa Ubs Ats	0.9M	42 sh
Sgmt Sigma X2	0.7M	35 sh
Mstx Ms Trajectory Cross (Ats-1)	0.6M	31 sh
Mlix Instinct X	0.6M	67 sh
Ebxl Level Ats	0.5M	16 sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Where a dollar of Solventum Corporation revenue goes. All values FY2025 filings, live. Product segmentation not yet parsed for this symbol — revenue shown unsegmented.

Region	Revenue	Share
UNITED STATES	$4.7B	56%
Non-US	$3.7B	44%

SOLV (live moat model)Peer median: BAX · HOLX · RGEN · AVTR · COO

Component scores from the live moat model. Peer median illustrative.

Moat score 54/100 — Weak; primary source Cost Advantage.

Officer	Title
Bryan C. Hanson	Chief Executive Officer & Director
Heather L. Knight	Chief Commercial Officer
Wayde D. McMillan	Executive VP & CFO
Amy Landucci	Chief Information & Digital Officer

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

Quarterly EPS — Actual vs. Consensus

Beats (>2%)6 of 6recent quarters

Avg Surprise+13.4%

Next Report2026-11-05

Income Quality0.15OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Profit Margins (%)

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+12.2%	-0.5%	+0.8%	+0.7%	+0.9%
Gross profit	+14.1%	-4.6%	-0.0%	-2.1%	-3.1%
Operating income	+31.4%	-9.9%	-0.1%	-38.8%	+110.5%
Net income	+28.3%	-8.0%	+0.2%	-64.4%	+224.8%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	8.2	8.1	8.2	8.3	8.3
Cost of revenue	3.2	3.4	3.5	3.7	3.9
Gross profit	4.9	4.7	4.7	4.6	4.5
R&D expense	0.8	0.8	0.8	0.8	0.7
SG&A expense	2.3	2.2	2.2	2.8	3.1
Operating income	1.9	1.7	1.7	1.0	2.2
EBITDA	2.5	2.3	2.2	1.5	2.5
D&A	0.6	0.6	0.6	0.6	0.5
Pretax income	1.9	1.7	1.7	0.6	1.7
Income tax	0.4	0.3	0.3	0.1	0.2
Net income	1.5	1.3	1.3	0.5	1.6
Diluted EPS ($)	8.47	7.79	7.79	2.76	8.88
Diluted shares (M)	172	172	173	174	175

Operating CF$0B

CapEx$0B

Free cash flow$-0B

SBC$0B

Buybacks$0B

Net cash change$0B

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Shown instead of the usual cash-distribution diagram because operating cash flow was not positive this year — there was no internally generated cash to distribute, so the decision-relevant question is what funded the spending. Sources left, uses right; cash is fungible and the statement does not trace which rupee of borrowing bought which asset, so the band is proportional, not a claim about specific flows. Any residual from FX translation is carried explicitly as Other / FX.

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.1	0.2	0.8	0.9
ST investments	0.0	0.0	0.0	0.0
Receivables (net)	1.2	1.3	1.2	1.0
Total current assets	2.2	2.5	3.2	3.9
PP&E (net)	1.3	1.5	1.6	1.3
Goodwill + intangibles	9.7	9.4	8.9	8.3
Total assets	13.6	13.9	14.5	14.3
Accounts payable	0.3	0.5	0.6	0.7
Short-term debt	0.0	0.0	0.2	0.0
Deferred revenue	0.6	0.6	0.6	0.6
Total current liabilities	1.3	1.7	2.7	3.1
Long-term debt	0.0	8.3	7.8	5.0
Total liabilities	1.9	2.3	11.5	9.2
Shareholders' equity	11.7	11.7	3.0	5.0

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	1.3	1.3	0.5	1.6
D&A	0.6	0.6	0.6	0.5
Stock-based compensation	0.0	0.0	0.1	0.2
Working capital change	(0.2)	0.1	0.2	(0.1)
Operating cash flow	1.7	1.9	1.2	0.4
Capital expenditures	(0.3)	(0.3)	(0.4)	(0.4)
Investing cash flow	(0.3)	(0.2)	(0.4)	2.8
Buybacks	0.0	0.0	0.0	0.0
Dividends paid	0.0	0.0	0.0	0.0
Debt issuance / (repay)	0.0	0.0	8.0	(3.1)
Financing cash flow	(1.5)	(1.6)	(0.2)	(3.1)
Free cash flow	1.4	1.6	0.8	(0.0)

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY24	FY25	TTM
PROFITABILITY
ROE	8.2%	38.9%	29%
ROA	1.7%	10.8%	10.1%
ROIC	5.6%	21.5%	15.9%
Gross margin	55.6%	53.5%	54.7%
Operating margin	12.6%	26.2%	25.0%
Net margin	5.8%	18.7%	17.3%
EBITDA margin	18.5%	30.6%	29.7%
FCF margin	7.5%	-0.1%	—
VALUATION
P/E	47.63	8.93	10.4
P/B	3.90	2.75	3.1
P/S	1.85	1.67	1.76
P/FCF	24.79	-1389.08	-123.8
EV/EBITDA	18.41	6.42	7.9
EV/Revenue	3.01	2.17	2.3
Earnings yield	2.1%	11.2%	9.63%
FCF yield	4.0%	-0.1%	-0.81%

Ratio	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.20	1.23	1.02
Quick ratio	0.84	0.89	0.74
Debt / equity	2.71	1.00	1.10
Debt / assets	55.4%	35.2%	37.1%
Net debt / EBITDA	7.11	1.48	1.98
Interest coverage	1.84	5.94	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.43	0.58	0.58
Receivables turnover	5.98	8.01	5.8
DSO (days)	61	46	63
DPO (days)	80	61	68
Cash conversion cycle	106	80	96
GROWTH (YoY)
Revenue growth	—	33.5%	—
Net income growth	—	543.0%	—
EPS growth	—	540.0%	—
FCF growth	—	-102.2%	—
PER SHARE ($)
EPS (diluted, TTM)	1.39	8.88	8.27
Book value / share	16.96	28.80	27.67
Revenue / share	35.75	47.49	47.90
FCF / share	2.66	-0.06	-0.68
Cash / share	4.37	5.01	2.32
SHAREHOLDER RETURN & SCORES
Buyback yield	0.0%	0.0%	2.64%
Altman Z-Score	1.24	2.20	2.2
Piotroski F-Score	4	6	7/9
Beneish M-Score	—	-2.21	-2.08

Model	Score	Zone	Note
Piotroski F-Score	7 / 9	Strong
Altman Z-Score	2.2	Grey zone	Grey
Income quality	0.15	Accrual-heavy	OCF ÷ net income
Beneish M-Score	-2.08	Elevated	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.85
Interest burden	0.86
Operating margin	23.6%
Asset turnover	0.57×
Financial leverage	3.47×
= ROE	34%

Growth Quality (live)	Value
Revenue stability	0.74
Earnings stability	0.90
Earnings persistence	0.50
Revenue CAGR 3y	—
EPS CAGR 3y	—
FCF CAGR 3y	—

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield2.64%

Dividend Yield0.00%none paid

Total Shareholder Return2.64%cash yield

SBC / Revenue2.0%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
BAX	$13.1B	-12.4	-16%	4.3%	+5.4%	3/9	+10.3%
HOLX	$17.0B	30.3	11%	17.1%	+2.2%	6/9	+13.2%
RGEN	$11.1B	237.1	2%	2.5%	+16.5%	8/9	+13.5%
AVTR	$11.1B	-19.6	-10%	2.3%	-1.6%	6/9	+12.7%
COO	$11.0B	19.8	7%	40.6%	+4.7%	6/9	—
ATR	$7.9B	22.2	14%	8.5%	+8.9%	6/9	—
WST	$27.0B	48.8	19%	17.7%	+12.4%	9/9	—
MDLN	$31.5B	41.8	3%	0.8%	—	4/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

12 Analysts

Str Sell (0)Sell (1)Hold (2)Buy (9)Str Buy (0)

Mean Target (qtr)$101.006 targets

Target vs. Price+17.7%last-quarter mean

Next Report2026-11-05street $1.35

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$8.24B	$8.28B / $8.12B	$7.16	$7.49 / $7.07	9
FY2027	$8.53B	$8.59B / $8.42B	$7.33	$7.71 / $6.55	9
FY2028	$8.87B	$9.00B / $8.69B	$8.07	$10.67 / $4.21	5

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Quarter	$101.00	+17.7%	6
Last Year	$92.74	+8.1%	19
All Time	$85.67	-0.2%	30

Rolling mean of published targets vs. last close $85.81. Aggregated from StreetInsider.

Third-Party Composite Rating

A-

DCF

4/5

ROE

5/5

ROA

5/5

Debt/Eq

1/5

P/E

3/5

P/B

3/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

SOLV +20.1% vs S&P 500 +15.9% — spread +4.2pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$87.69	-1.88	-2.14%	Below
SMA 50	$88.43	-2.62	-2.96%	Below
SMA 200	$78.26	+7.55	+9.65%	Above
EMA 9	$86.85	-1.04	-1.20%	Below
EMA 21	$87.48	-1.67	-1.91%	Below
EMA 50	$86.95	-1.14	-1.31%	Below
EMA 200	$80.50	+5.31	+6.60%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

TECHNICAL VERDICTLEAN BEARISHPower Score -277 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%33

Momentum 25%30

Volume 20%50

Volatility 10%17

Patterns 15%50

This Week18% bullishof 11 price-based votes

4 Weeks Ago45%-27 pts since

12 Weeks Ago45%-27 pts since

ReadDeterioratingweek-over-week trajectory

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Price vs SMA 20$87.69

Price vs SMA 50$88.43

Price vs SMA 200$78.26

EMA 9/21 Cross86.8/87.5

SMA 50/200Golden

ADX DirectionADX 17

Supertrend$91

Parabolic SAR$83

SMA Slope-0.150

RSI42.4

Stochastic K/D56/52

StochRSI K/D58/50

Williams %R-62

CCI-78

TSI vs Signal-9.9

CMO-15.3

ROC-2.33%

OBV SignalAccum

Chaikin MF-0.060

MFI39

Force Index-0M

Elder Ray Bull1.22

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 52

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$88.19 / $89.12 / $90.38	S1 / S2	$86.93 / $86.00
Bollinger (20,2)	$85.23 – $90.16	Squeeze	ON
52-wk range	$62.38 – $94.16	Off 52-wk high	-8.9%
ATR (14)	$2.17 (2.5%)	Historical vol	16.7%

Computed from live weekly prices	SOLV	S&P 500
Weekly volatility (σ, 1y)	4.86%	1.83%
Best / worst week (1y)	+14.1% / -9.7%	—
Max drawdown (5y, monthly)	-26.1%	—
1-week VaR (95%)	-7.2%	—
Beta (5y)	0.69	1.00

SOLV EQUITY WEATHER (LIVE)CLOUDY · -12

Trend-25

Momentum-10

Volume+29

Volatility-30

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Average sentiment of 114 stories, weekly buckets, −1 to +1.

Overall-11.6-1.3 vs industry

Trend-24.9-25.7 vs industry

Momentum-9.6-8.5 vs industry

Volume+28.9+11.8 vs industry

Reading	SOLV	Medical - Instruments & Supplies n=284	Healthcare n=5,272	All US symbols n=70,435
Overall	-11.6	-10.3	-24.0	-20.5
Trend	-24.9	+0.7	-25.6	-21.3
Momentum	-9.6	-1.1	-28.5	-15.8
Volume	+28.9	+17.1	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Pillar (live disclosure scores)	Score
Environmental	39
Social	66
Governance	64
Composite ESG	56

Filed	8-K contents	Items
2026-08-05	Earnings Release; Exhibits	2.02,9.01
2026-08-05	Regulation FD; Other Events; Exhibits	7.01,8.01,9.01
2026-07-20	Officer/Director Change	5.02
2026-06-05	Other Events; Exhibits	8.01,9.01
2026-05-27	Officer/Director Change; Exhibits	5.02,9.01
2026-05-20	Shareholder Vote	5.07
2026-05-05	Earnings Release; Exhibits	2.02,9.01
2026-03-24	Officer/Director Change; Exhibits	5.02,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	10 rows · 2024-05-09 to 2026-08-05
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	10 rows · 2024 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-05-15 to 2026-09-01
Proposed sales (Form 144)	edgar/form144	not present for this symbol
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2025-08-18 to 2026-03-27
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Solventum Corporation (SOLV)

Institutions holding — 10 quarters

Solventum Corporation (SOLV)

Monthly Net Insider Flow (000 shares)

Signal Summary

Solventum Corporation (SOLV)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding SOLV — quarterly

Institutional Put/Call — quarterly

Where SOLV Trades in the Dark

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Balance Sheet — Full

Cash Flow Statement — Full

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Street Price Target — Trajectory

Third-Party Composite Rating

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Family Scores (site weights)

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)